Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Schizophrenia
Interventions
DRUG

Flunarizine

For 1 week, 40 mg/day. From week 2 to 3, 20 mg/day. Form week 4 onwards, dosage increment or reduction of 10mg/day was allowed according to efficacy and tolerability.

Trial Locations (1)

04023-900

Universidade Federal de São Paulo, São Paulo

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Ambulatório de Bipolaridade

OTHER

NCT00740259 - Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol | Biotech Hunter | Biotech Hunter